Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2025 08:00 ET | Source: Boehringer Ingelheim Limited

Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases

Boehringer has licensed CDR111 from CDR-Life, an antibody-based trispecific M-gager® for autoimmune diseases.